Zydus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and eighteen approved drugs.
Drugs and US Patents for Zydus Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Pharms | MEMANTINE HYDROCHLORIDE | memantine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 203293-002 | Aug 3, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Zydus Pharms | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208052-003 | Mar 19, 2019 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Zydus Pharms Usa | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040663-002 | May 30, 2006 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Zydus Pharms Usa Inc | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 078243-001 | Oct 6, 2010 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.